Greenwich LifeSciences, Inc.

NASDAQ:GLSI

13.81 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -8.892-7.825-4.571-1.863-3.425-1.69-1.573
Depreciation & Amortization 0.0040.0040.0040.0040.0040.0040.004
Deferred Income Tax -0.035-1.751-1.195-0.778000
Stock Based Compensation 2.3781.7440.6610.6780.19500
Change In Working Capital 0.032-0.122-0.3850.0282.9331.5711.449
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0.0350-0.527-0.0930.3930.0810.145
Other Working Capital -0.004-0.1220.1420.1212.541.491.304
Other Non Cash Items 0.0351.7511.1950.778-0-0.074-0.138
Operating Cash Flow -6.479-6.2-4.292-1.153-0.293-0.115-0.121
Investing Activities:
Investments In Property Plant And Equipment 0000000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow 0000000
Financing Activities:
Debt Repayment 000-0.36000
Common Stock Issued 003.11130.16700.10
Common Stock Repurchased 0-7.5360000-0.09
Dividends Paid 0000000
Other Financing Activities 0-0.008-0.275-0.360.2150.2-0.04
Financing Cash Flow 0-7.5362.83529.8070.2150.2-0.13
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -6.479-13.736-1.45628.654-0.0780.085-0.251
Cash At End Of Period 6.98913.46827.20428.660.0070.0850